摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-bis(N-pyrrolidinylmethyl)-4-hydroxyaniline | 85236-51-7

中文名称
——
中文别名
——
英文名称
3,5-bis(N-pyrrolidinylmethyl)-4-hydroxyaniline
英文别名
2,6-bis<(N-pyrrolidinyl)methyl>-4-aminophenol;4-amino-2,6-bis(pyrrolidin-1'-ylmethyl)phenol;2,6-bis-(1-pyrrolidinomethyl)-4-aminophenol;4-Amino-2,6-bis(pyrrolidin-1-ylmethyl)phenol
3,5-bis(N-pyrrolidinylmethyl)-4-hydroxyaniline化学式
CAS
85236-51-7
化学式
C16H25N3O
mdl
——
分子量
275.394
InChiKey
ZCVLBPMYDFQUBD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    218-219 °C
  • 沸点:
    429.3±45.0 °C(Predicted)
  • 密度:
    1.210±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    52.7
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:f32deadd27c494195db0ef812554163d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    3,5-bis(N-pyrrolidinylmethyl)-4-hydroxyaniline 生成 N-[4-hydroxy-3,5-bis(pyrrolidin-1-ylmethyl)phenyl]-2-(trifluoromethyl)benzamide;dihydrochloride
    参考文献:
    名称:
    STOUT, D. M.;MATIER, W. L.
    摘要:
    DOI:
  • 作为产物:
    描述:
    对乙酰氨基酚盐酸 作用下, 以 乙醇 为溶剂, 反应 6.0h, 生成 3,5-bis(N-pyrrolidinylmethyl)-4-hydroxyaniline
    参考文献:
    名称:
    Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 1. Heteroarylamine derivatives
    摘要:
    Twenty-four structural derivatives of the antiarrhythmic drug changrolin were synthesized and tested for antiarrhythmic and parasympatholytic activities. It was found that while the bis(pyrrolidinylmethyl)phenol pattern of changrolin appeared to be optimal in this series, a wide latitude existed for the heteroaryl substituent for maintaining good antiarrhythmic activity. Further, the antiarrhythmic and parasympatholytic activities tended to exhibit parallel changes.
    DOI:
    10.1021/jm00360a005
点击查看最新优质反应信息

文献信息

  • Potential Antimalarials. IX. Di-mannich Bases of 4-(7′-trifluoro-methylquinazolin-4′-ylamino)phenol and 4-(7′-Trifluoromethylquinolin-4′-ylamino)phenol
    作者:GB Barlin、C Jiravinyu
    DOI:10.1071/ch9900311
    日期:——

    Syntheses are reported for a series of di-Mannich bases of 4-(7′-trifluoromethylquinazolin-4′-ylamino)phenol derived from 4-chloro-7-trifluoromethylquinazoline with the di-Mannich bases of 4-aminophenol. Some analogous quinolines were prepared similarly. When tested for antimalarial activity against Plasmodium falciparum in vitro, the quinazolines were rather less active than the corresponding quinolines.

    报告了一系列 4-(7′-三氟甲基喹唑啉-4′-基氨基)苯酚二曼尼希碱的合成,这些苯酚二曼尼希碱来自 4-氯-7-三氟甲基喹唑啉和 4-氨基苯酚的二曼尼希碱。一些类似的喹啉类化合物也是用类似方法制备的。在对恶性疟原虫进行体外抗疟活性测试时,这些喹唑啉类化合物的活性比相应的喹啉类化合物低。
  • Phthalazine compounds, compositions and use
    申请人:American Hospital Supply Corporation
    公开号:US04466965A1
    公开(公告)日:1984-08-21
    The present invention relates to new compounds of the formula ##STR1## alkylene, or --S-- where R.sub.1 is hydrogen, alkyl, or aryl; W is hydrogen, hydroxy, amino, alkyloxy, aryloxy, O-alkyl, or O-aralkyl; (Y).sub.A is --CH.sub.2 NR.sub.2 R.sub.3 where R.sub.2 and R.sub.3 may be hydrogen, substituted alkyls, aryls, or together with N form a 5 to 7 membered heterocyclic group; and Ar is a substituted or unsubstituted heteroaryl. These compounds are useful in the treatment of various cardiac arrhythmias.
    本发明涉及新化合物,其化学式为##STR1##其中R.sub.1为氢、烷基或芳基;W为氢、羟基、氨基、烷氧基、芳氧基、O-烷基或O-芳基;(Y).sub.A为--CH.sub.2 NR.sub.2 R.sub.3,其中R.sub.2和R.sub.3可以是氢、取代烷基、芳基,或与N一起形成5到7元杂环基;Ar为取代或未取代的杂芳基。这些化合物在治疗各种心律失常中有用。
  • N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
    申请人:Shanghai Institute of Materia Medica Chinese Academy of Science
    公开号:US06605635B1
    公开(公告)日:2003-08-12
    N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)benzyl aromatic sulfonamides and N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)phenyl aromatic sulfonamides compounds in accordance with the animal test, are active in the prevention and the treatment of cardiac arrhythmia. These compounds are prepared as corresponding diamines by the condensation of optionally substituted aromatic sulfochlorides with p-hydroxybenzylamine, p-aminophenol, or the like, which followed by the Mannich reaction of the resulted corresponding aromatic sulfamides with formaldehyde and secondary amines; or directly obtained by the reaction of the aromatic sulfamides with 4-amino-2,6-bis-disubstituted aminomethylphenol. Subsequently, the diamines are reacted with various acids to provide their salts.
    根据动物测试,N-(3,5-双取代氨甲基-4-羟基)苯甲醇磺酰胺和N-(3,5-双取代氨甲基-4-羟基)苯基磺酰胺化合物在预防和治疗心律失常方面具有活性。这些化合物通过选择性取代的芳香基磺酰氯与对羟基苯甲胺、对氨基苯酚等缩合生成相应的二胺,然后将所得的芳香基磺酰胺与甲醛和二级胺进行Mannich反应制备;或直接与4-氨基-2,6-双取代氨甲基苯酚反应得到。随后,这些二胺与不同的酸反应形成它们的盐。
  • Heteroaryl substituted aminomethyl benzene derivatives, compositions and use
    申请人:THE DU PONT MERCK PHARMACEUTICAL COMPANY
    公开号:EP0310155A1
    公开(公告)日:1989-04-05
    New compounds of the formula (I) where X is straight-chained alkylene, or -S- wherein R1 is hydrogen, aryl, or lower alkyl; W is hydrogen, hydroxy, amino, , 0-alkyl, alkylsulfonamide or O-aralkyl; (Y)A is positioned ortho to W and is an aminoalkyl having the formula -CH2NR2R3, wherein R2 and R3 are the same or different and may be hydrogen, lower alkyl, hydroxyalkyl, cycloalkyl, alkoxyalkyl, alkoxyaryl, aryl, heteroaryl, or R2 and R3 may together with N form a 5 to 7 membered heterocyclic group optionally including oxygen, nitrogen, or sulfur as a second hetero-atom, and A is 1 or 2; N and M are independently from O to about 5; and Ar is a substituted or unsubstituted pyridine optionally fused with one or more heteroaryls and pharmaceutically acceptable salts of such compounds are useful in the treatment of various cardiac arrhythmias.
    式 (I) 的新化合物 其中 X 是 直链亚烷基,或 -S- 其中 R1 是氢、芳基或低级烷基;W 是氢、羟基、氨基、 其中 R2 和 R3 相同或不同,可以是氢、低级烷基、羟基烷基、环烷基、烷氧基烷基、烷氧基芳基、芳基、杂芳基,或 R2 和 R3 可与 N 一起形成 5 至 7 个成员的杂环基团,任选包括氧、氮或硫作为第二个杂原子,且 A 为 1 或 2;N 和 M 独立地从 O 到约 5;Ar 是取代或未取代的吡啶,可选与一个或多个杂芳基融合,此类化合物的药学上可接受的盐类可用于治疗各种心律失常。
  • N-SUBSTITUTED BENZYL OR PHENYL AROMATIC SULFAMIDES COMPOUNDS AND THE USE THEREOF
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:EP1245561A1
    公开(公告)日:2002-10-02
    N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)benzyl aromatic sulfonamides and N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)phenyl aromatic sulfonamides compounds in accordance with the animal test, are active in the prevention and the treatment of cardiac arrhythmia. These compounds are prepared as corresponding diamines by the condensation of optionally substituted aromatic sulfochlorides with p-hydroxybenzylamine, p-aminophenol, or the like, which followed by the Mannich reaction of the resulted corresponding aromatic sulfamides with formaldehyde and secondary amines; or directly obtained by the reaction of the aromatic sulfamides with 4-amino-2,6-bis-disubstituted aminomethylphenol. Subsequently, the diamines are reacted with various acids to provide their salts.
    根据动物试验,N-(3,5-二取代氨甲基-4-羟基)苄基芳香族磺酰胺和 N-(3,5-二取代氨甲基-4-羟基)苯基芳香族磺酰胺化合物在预防和治疗心律失常方面具有活性。这些化合物是通过任选取代的芳香族磺酰氯与对羟基苄胺、对氨基苯酚或类似物缩合,然后将生成的相应芳香族磺酰胺与甲醛和仲胺进行曼尼希反应制备成相应的二胺;或者直接通过芳香族磺酰胺与 4-氨基-2,6-二取代氨甲基苯酚反应制备成二胺。随后,二胺与各种酸反应生成它们的盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐